Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns
Japan sees ‘drug lag’ as foreign pharmas pass up the [...]
Japan sees ‘drug lag’ as foreign pharmas pass up the [...]
NICE delays decision on Roche’s Evrysdi but will allow its [...]
Biogen’s Aduhelm ‘likely’ linked to Alzheimer’s patient’s death, RBC analyst [...]
Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial [...]
GSK’s Cabenuva scores thumbs up from England’s NICE, giving HIV [...]
AHA: J&J’s Invokana chases AZ’s Farxiga and Lilly’s Jardiance with [...]
AHA: Eli Lilly and Boehringer Ingelheim’s Jardiance stays on its [...]
Thermo Fisher will build lab supply plant in North Carolina [...]
GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug [...]
AstraZeneca’s star China business slows on Tagrisso price cut, but [...]